Rebel
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So you're saying that Roger is still in charge and perhaps Melinda Rice? That wouldn't be surprising, but is in direct contradiction to what we were recently told by the former IR person--that they had "stepped down." Would you care to explain?
I am interested in this "presentation" you attended last fall. Was Roger Pawson the presenting party? Did this alleged presentation revolve around the hybridization business? Are you the owner of either the "hybridization company" or the "California trucking company" with whom they've contracted? Perhaps you are involved in the construction of the five West coast commercial vehicle hybridization installation centers for CBAY that we were told about in December?
Could it be that things have changed (i.e., BLOWN UP) since last fall when you saw the presentation and read the business model? Thank you in advance for your response.
This is fairly normal for CBAY. It's siesta time, that's all.
There's really nothing to do but wait it out with happy smiles as we look forward to a bright and prosperous future.
(did I say that?)
It looks like Goldman Sachs still holds the most shares with 442,529, with Vanguard coming in second with 192,523. They can't be too worried...I wonder what they know that we don't know and when they knew it.
http://www.mffais.com/vnbc.html
Institutional investors are stepping up. Vanguard is in for over 4.7 million shares, reported 2/3/09, and there are several others with recent buys, including Ohio and Florida State Employees/Retirement Systems.
Hmmmm...very (very) cool.
http://www.mffais.com/fbr.html
Itkstock, just who are these "people" you've spent time with?
And what are these "other things" the company is involved with? Is the hybridization deal still a "thing?" Or are we now going to morph into another "thing," such as composting bins or steam mops? Oh, please...do share.
Hello Palacian. Yes, maybe it will be a big sunfish who would be willing to pay for the report, and if he does, then I'm quite sure he would be happy to share the info with this board.
;)
BIPH included in research report...2/5/09:
Research and Markets: Global Nanomagnetics Strategic Business Report Analyses the Worldwide Market in Terms of US$ Millions
Feb 5, 2009 21:00:00 (ET)
DUBLIN, Ireland, Feb 05, 2009 (BUSINESS WIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/e37a3f/nanomagnetics_gl ) has announced the addition of the "Nanomagnetics - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Nanomagnetics in US$ Million. The major product segments analyzed are Particulate Products, Bulk Materials, and Thin Films. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific , and Rest of World. Annual forecasts are provided for each region for the period of 2003 through 2015. The report profiles 38 companies including many key and niche players worldwide such as ADEMTECH SA, Alps Electric Co., Ltd, Amag Pharmaceuticals Inc., Bangs Laboratories, Inc., Bayer Schering Pharma AG, Biophan Technologies, Inc, Cathay Pigments (USA) LLC - Cathay Magnetics, Chemagen Biopolymer-Technologie AG, Cortex Biochem, Inc, Dowa Holdings Co., Ltd., EMD Biosciences, Inc, Ferrotec (USA) Corporation, Fujitsu Laboratories, Ltd, Headway Technologies, Inc, Hitachi Metals, Ltd, IBM Corp, IBM Research Centers Nanoscience, Immunicon Corporation, Liquids Research Ltd, MACH we Inc, Magforce Nanotechnologies Gmbh, MAGNETEC GmbH, Micromod Partikeltechnologie GmbH, Nanobiomagnetics, Inc, NVE Corp., Polysciences, Inc, Quantum Design, Triton Biosystems, Inc, Vacuumschmelze GmbH & Co. KG, and WD Media, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. Executive Summary
1. Industry Overview & Outlook
2. Nanomagnetics Market
3. Trends and Issues
4. Product Overview
5. End-Use Market Analysis
6. Technological Developments/Breakthroughs
7. Product Innovations/Introductions
8. Focus on Select Players
9. Global Market Perspective
III. MARKET
1. The United States
2. Japan
3. Europe
4. Asia-Pacific
5. Rest of World
IV. COMPETITIVE LANDSCAPE
Companies Mentioned:
Ademtech Advanced Magnetics, Inc ALPS Electric Co, Ltd Biophan Technologies, Inc Center For Nanoscale Systems Chemagen Biopolymer-Technologie AG Cortex Biochem, Inc Dowa Mining Co, Ltd ( EMD Biosciences, Inc Ferrotec (USA) Corporation Fujitsu Laboratories Ltd Headway Technologies Hitachi Metals Ltd International Business Machines Corporation (IBM) Immunicon Corporation Inframat Corporation Invitrogen Corporation Institute of Physical and Chemical Research ISK Magnetics Komag, Inc Liquids Research Ltd Mach I, Inc Magforce Nanotechnologies AG Magnetec GmbH Micromod Partikeltechnologie GmbH Nanobiomagnetics, Inc Nanomagnetics And Spin Dynamics Group Nanomagnetics Instruments Ltd Nanomagnetics Ltd National University of Singapore NVE Corporation Osaka University Polysciences, Inc Quantum Design Schering AG Small Times Media LLC Triton Biosystems, Inc Vacuumschmelze GmbH
For more information visit http://www.researchandmarkets.com/research/e37a3f/nanomagnetics_gl
SOURCE: Research and Markets
Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Someone just bought 500 shares at .43 in PM, a 207% increase.
Seems crazy. Ask is now at .19.
Human Genome Shares Jump On Start Of Anthrax-Drug Deliveries Dow Jones
RELATED QUOTES
3:10 PM ET 2/2/09
Symbol Last % Chg
HGSI 2.38 31.49%
Real time quote.
By Shara Tibken
Of DOW JONES NEWSWIRES
NEW YORK (Dow Jones)--Shares of Human Genome Sciences Inc. (HGSI) rose as much as 24% on Monday after the genome researcher said it started delivering its treatment for inhalation anthrax.
"This is one more step, a new approach if you will, to counter the anthrax risk," Chief Executive H. Thomas Watkins said in an interview on cable news station CNBC. "It will provide our nation one more step, an important step, in the arsenal against bioterrorism."
The company said Monday that it has begun delivering 20,000 doses of ABthrax to the U.S. Strategic National Stockpile to be used to treat anthrax. It expects to receive $150 million in revenue shortly after completing delivery.
Shares jumped 22% to $2.21 in recent trading and rose as high as $2.24 earlier Monday. Shares are still down about 62% for the year and are well off their 52-week high of $8 in August.
Analysts at JPMorgan said the delivery of the drug initially was expected last year but was delayed, raising concerns about Human Genome's balance sheet.
"While such concerns still persist, the news today should be an incremental positive, as it diminishes near-term uncertainty, and as such, we expect HGSI shares to react favorably," the firm said in a note.
ABthrax works along with other anthrax drugs or on its own, targeting toxins released by anthrax-causing bacteria.
Watkins said current anthrax antibiotics target the bacteria causing the infection, not the toxins released by the bacteria.
"It's the toxins that are really the biggest threat," Watkins said on CNBC. "Because if someone's exposed, they may not know they're really exposed." He added that most of the deaths in 2001 from anthrax were actually from the toxins.
-By Shara Tibken, Dow Jones Newswires; 201-938-2168; shara.tibken@dowjones.com
There are about 11 million shares short here...plus there should be plenty of new investors wanting in.
Poor, poor shorts.
;)
Yikes...Human Genome starts shipping new anthrax drug A7:00 AM ET 2/2/09 | Reuters
RELATED QUOTES
9:00 PM ET 1/30/09
Symbol Last % Chg
HGSI 1.81 0.00%
Real time quote.
By Maggie Fox, Health and Science Editor
WASHINGTON, Feb 2 (Reuters) - Human Genome Sciences Inc. (HGSI) said on Monday it was beginning delivery of 20,000 doses of ABthrax, which fights anthrax infection, to the U.S. government.
It is the first sale for the biotechnology company, which has struggled to get a product onto the market.
The drug takes a new approach to fighting bacterial infection by targeting the toxin made by the anthrax bacillus instead of the microbe itself.
ABthrax, known generically as raxibacumab, is a human monoclonal antibody -- a lab-engineered immune system protein. This one is designed to attack and neutralize the toxic compound that makes anthrax so deadly.
The U.S. government contracted with the Maryland-based biotech firm to make the drug in case of a biological attack under Project BioShield, the company said.
Anthrax is a fairly common bacteria and usually causes an easily treated skin lesion. But if inhaled, it can take hold quickly and by the time a person starts showing symptoms, it is usually too late for successful treatment with antibiotics.
This is because the bacteria pump out toxins that are not affected by antibiotics and that persist after the bacteria are dead.
There is an anthrax vaccine but it must be given before exposure.
LETTER ATTACKS
In October 2001, soon after the Sept. 11 attacks, letters carrying powdered anthrax killed five people and sickened 13 more. Federal investigators have blamed Dr. Bruce Ivins, an anthrax vaccine researcher at Fort Detrick in Maryland.
Ivins killed himself last year before he could be charged.
Bioterrorism experts say anthrax is a very likely weapon of choice for future attacks.
"In contrast to the anthrax vaccine, the protection afforded by a single dose of ABthrax would be immediate following the rapid achievement of appropriate blood levels of the medication, making it potentially useful for 'first responders' and members of the military," the company said in a statement.
Animal studies have shown Abthrax provides 100 percent protection if given before inhaling anthrax. One dose after exposure improves an animal's survival odds by 64 percent.
The U.S. Food and Drug Administration, which has not yet licensed the drug, accepts data from two animals in lieu of human tests for certain deadly infections.
"HGS has also completed safety studies of ABthrax in more than 400 human volunteers. The clinical results to date suggest that ABthrax was generally safe and well tolerated," the company said.
"We believe ABthrax offers a significant step forward in the treatment of inhalation anthrax and could play an important role in strengthening America's arsenal against bioterrorism," said H. Thomas Watkins, president and chief executive officer of Human Genome Sciences.
"From a business perspective, this announcement is strategically important for HGS, because it marks our company's first product sales.
HGS expects $165 million in revenues from the award, with $150 million in the first half of 2009, following delivery of 20,000 doses of ABthrax, and the rest when the FDA licenses it.
The company is also working to license Albuferon for patients with hepatitis C and LymphoStat-B for lupus, as well as cancer drugs. (Editing by Doina Chiacu)
Right here: SWK Technologies, Inc. (TYRIA's subsidiary) out of Livingston, NJ (not yet a Big Kahuna, but a Million Dollar Achiever--for the 3rd time).
http://www.sagenorthamerica.com/company/newsroom/press_releases/details?CID=1D530152-BBB0-0001-8944-C9E015B01386&CardId=45803&RowIndex=26&Product=*&Year=*
This is where they're being honored this weekend by Sage Software for being a "Million Dollar Achiever" for the 3rd consecutive year in Hawaii, lucky dogs. While there are clearly cash flow and other problems, such as negative shareholder equity and "going concern" issues, TYRIA seems to be a robust, growing business with some pretty impressive revenues and partners. I have to wonder why the share price just sits at .0001 with no bid and a market cap of only about $410,000.
http://kauai.hyatt.com/hyatt/hotels/index.jsp
Link wouldn't work because you'd have to log into my account. If anyone has E-Trade, you'll see it. Tried copying/pasting and this is the sorry result:
Analyst Research More » Thomson Reuters
Last Reported 1/28/09...then "Outperform is highlighted in blue.
Thomson-Reuters now rates TYRIA as "outperform," which seems highly unusual for a .0001 stock.
So Cal-Bay International again went into default on Friday, 1/23 with the SOS, and tomorrow we'll probably see the reservation of "Cal-Bay USA, Inc." expire. Reasons enough for Roger to "step down" again. So much for returning CBAY to its "FORMER GLORY." lolol.
Yes, I need an attitude check (slapping myself around right now. Ouch, ouch).
Are we entering still another black hole with months and months ahead of nothingness? I wonder if Roger "stepped down" just to get everyone, including Dale, off his back.
I love this company (so much). I know you do too.
Is there, in fact, a new Board of Directors and/or new officers? I mean right now? Or is CBAY simply for sale as a shell with some serious issues? Thanks and good luck with your shares.
The reserved name, "Cal-Bay USA, Inc." expires on Tuesday, 1/27/09. Place your bets on whether or not they will file their corporate papers by then, or even apply for an extension and/or issue the dividend as PR'd.
Roger resigned? Again? lolol.
So everything Melinda said in her "President's letter" on 1/17/09 is now meaningless less than a week later?
The craziness continues...Go CBAY!
If you enter .06, chances are very good that you'll get your shares at .054 or .055 if they're available--I do it all the time.
Ararat is a doctor and probably a crook from Turkey and his LLC allowed CBAY to purchase some real estate by an assumption of the first mortgage in a rather convoluted deal that also included cash and Preferred B CBAY shares to Ararat. Those shares were subsequently cancelled with the understanding that Ararat was still OWED shares in CBAY. The property consisted of about 280 acres in Florida ("Stonewall Estates"). To make a very long story short, CBAY subsequently sold the property to Lennar Homes and the proceeds from that sale have yet to be distributed (to the best of my knowledge). CBAY believes it is owed about $14 million. The courts ruled against CBAY twice and even told CBAY not to pursue the matter again, but CBAY brought the matter to another court in California anyway, and I just don't know the current status of that case. I do remember, however, that the California court was confused as to WHY CBAY thought the case belonged in California and had demanded an explanation from CBAY, and that the defendants had filed a Motion to Dismiss. I stopped following the case when my last hard drive blew up and I decided that it probably wouldn't matter anyway.
Is CBAY owed $14 million? I have NO IDEA, but CBAY apparently continues to believe that it is entitled to that money (but maybe they just want new investors and shareholders to believe that they believe that they are entitled?? You just never know with these crazy people).
Mordicai or Keymaster or anyone else, please feel free to correct me--as I am sure you can understand, following this stock has been rather taxing (or toxic) on my cerebellum.
Go CBAY to .025...yippee!
Thanks for posting that. Melinda/Roger should have had someone proofread this letter before releasing it.
This part sort of cracks me up:
"Maintain more market stability in the company's stock price."
It seems to me that a share price from .0001 to .0001 to .0001 no matter how huge the volume is a good indication that CBAY already HAS a very stable stock price.
(lol)
It is mind-numbing that CBAY is again in default with the Nevada SOS.
Go CBAY!
And two years ago yesterday, it closed at $40.00 on volume of 50.
(lol)
"But will Wang make my share worthless again- I'm too damn scared to do it."
I agree with you that it's tempting, and yours seems to be the current sentiment. CHBO could either be an unbelievable, once-in-a-lifetime investment, or these cheap shares could just lead us up to another R/S.
Nothing to do but watch and wait (and buy if you dare!).
;)
Who knows. According to pinksheets.com, there were ZERO shares short as of 12/31. BTW, at pinksheets, they're stating the market cap is $4.5 million as of 1/16/09. I'd like to know if they're still issuing shares to their creditors and/or how they funded the completion of the acquisitions. It appears Wang and his family still own a substantial number of shares, which is a good thing.
P.S. From what I can tell, the R/S done in July was the only one ever done, unless I'm missing something.
Ran into this article about CHBO being on the naked short list for 13 consecutive days, which is supposed to trigger the closing out of any fail-to-deliver positions. If that happened, it didn't do much good for the share price. I have sent a few questions to the company and will post if I hear back from them.
http://www.individual.com/story.php?story=94780016
Yes, there was a big-boy buy of 45,410 shares at precisely 4 p.m. (according to my brokerage account)
(lol)
Bid is now .17/Ask is .39.
Crazy times.
Carl Icahn is at it again...
http://ih.advfn.com/p.php?pid=nmona&cb=1231335029&article=35034422&symbol=NB%5EXOHO
XO Communications SIP Solution Attains SIPconnect Compliant Certification From SIP ForumFont size: A | A | A8:01 AM ET 1/7/09 | Market Wire
RELATED QUOTES
8:54 PM ET 1/6/09
Symbol Last % Chg
XOHO 0.19 0.00%
Real time quote.
XO Communications (OTCBB: XOHO) today announced that it has achieved SIPconnect Compliant certification from the SIP Forum, a leading independent IP communications industry association comprised of individuals and companies who contribute to the development of global IP communications based on the SIP standard.
SIPconnect Compliant certification helps assure businesses and large enterprises that XO SIP, XO's award-winning SIP-based integrated voice and data communications solution, will interoperate seamlessly with SIPconnect-compliant IP-PBX systems.
The SIPconnect Technical Recommendation, an initiative of the SIP Forum, was designed to encourage a standards-based approach to SIP trunking. SIP, or Session Initiation Protocol, is a signaling protocol used for advanced voice, messaging and conferencing services and is the technology of choice for real-time multimedia communications in corporate networks. The SIPconnect Compliant program offers a unique certification to validate and ensure interoperability among equipment manufacturers, software providers and service providers, as well as to promote further adoption of SIP as the standard for IP communications.
"SIPconnect certification tells customers that they will enjoy increased interoperability levels Between XO SIP and their IP telephony infrastructure," said Nicola Jackson, director of voice and converged services at XO Communications. "The SIPcompliant certification is helping to create compliance and standards for SIP, which is extremely important as SIP continues to be deployed more widely by businesses and large enterprises as their preferred communications protocol."
"The SIP Forum is honored to have XO Communications join the ranks of other leading IP communications companies that have successfully achieved SIPconnect Compliant certification," said Marc Robins, managing director of the SIP Forum. "XO Communications participation in the SIPconnect Compliant Program not only speaks to the value of such a vital initiative, but also clearly demonstrates XO Communications' deep commitment to offering standards-based, highly-interoperable SIP trunking services."
XO SIP
XO SIP is a fully integrated communications solution designed to support the needs of businesses with the most demanding voice and data applications at single or multiple locations. SIP uses a native IP-based facility to manage all traffic between a customer's IP-PBX system, the XO IP network, and the Public Switched Telephone Network. The solution provides greater efficiencies by eliminating the need for businesses to maintain multiple access facilities for voice and data services and eliminates the need for bandwidth-consuming protocol conversions.
XO SIP includes a broad range of bandwidth options to maintain optimal network performance and has the following features:
-- Dedicated Internet access with dynamic bandwidth allocation -- Unlimited local calling -- Unlimited site-to-site calling for multi-location customers with IP Flex, IP Flex with VPN and XO SIP locations -- Long distance calling with choice of calling plans -- Optional Voice Compression -- Online Feature Management through the XO Business Center
XO SIP is interoperable with leading IP-PBX systems. For more information about XO services go to www.xo.com, or to speak with an XO sales representative, call (866) 349-0134.
About XO Communications
XO Communications, a subsidiary of XO Holdings, Inc. (OTCBB: XOHO), is a leading nationwide provider of advanced communications services and solutions for businesses, enterprises, government, carriers and service providers. Its customers include more than half of the Fortune 500, in addition to leading cable companies, carriers, content providers and mobile network operators. Utilizing its unique combination of high-capacity nationwide and metro networks and broadband wireless capabilities, XO offers customers a broad range of managed voice, data and IP services with proven performance, scalability and value in more than 75 metropolitan markets across the United States. For more information, visit www.xo.com.
About the SIP Forum
The SIP Forum is an IP communications industry association that engages in numerous activities that advance and promote SIP technology, such as the development of industry recommendations, the SIPit interoperability and testing events, special interoperability workshops and general promotion of SIP in the industry. One of the Forum's recent technical activities is the development of the SIPconnect Technical Recommendation -- a standards-based recommendation that provides detailed guidelines for direct IP peering and interoperability between IP PBXs and VoIP service provider networks, and the SIPconnect Compliant Certification Program through which eligible companies can gain SIPconnect validation and the right to license the use of the SIP Forum's 'SIPconnect Compliant' certification mark -- the official brand of the leading standard for SIP Trunking products and services. For more information, please visit: http://www.sipforum.org.
Media Contacts: Chad Couser XO Communications 703-547-2746 Email Contact Marc Robins SIP Forum 718-548-7245 Email Contact
SOURCE: XO Communications
XO Communications Launches Carrier-Grade MPLS IP-VPNFont size: A | A | A8:01 AM ET 1/7/09 | Market Wire
RELATED QUOTES
8:54 PM ET 1/6/09
Symbol Last % Chg
XOHO 0.19 0.00%
Real time quote.
XO Communications (OTCBB: XOHO) today announced the launch of XO Carrier MPLS IP-VPN, a wide area networking service engineered to meet the needs of current and future carrier customers. Designed to deliver secure, multi-point IP transport of VoIP, video, data applications and "in the cloud" computing services over one network, Carrier MPLS IP-VPN is the optimal solution for customers looking to extend their network with the latest and most efficient, cost-effective networking technology.
In addition to offering the standard IP-VPN services such as Class of Service (CoS) traffic routing, the carrier-specific product provides customers with:
-- Multiple VPN support across the same interface (up to 10Gbps); -- The ability to create global private networks through an inbound Network-to-Network Interface (NNI) with U.S. termination; -- Access to XO's Web Portal for service level monitoring and review of usage reports 24/7; and -- A management VPN feature that enables Carrier customers to provide their end-users with value-added services.
"The services provided through our Carrier MPLS IP-VPN offering demonstrate XO's commitment to creating value-added products for carrier customers," said Don MacNeil, vice president of XO Carrier Services Operations. "Rather than simply repackaging our MPLS IP-VPN business solution for wholesale, we've added strategic options that allow carriers to use proven, cost-effective solutions for network growth, management and security."
Specifically, XO Carrier MPLS IP-VPN can help international service providers expand their footprint; systems integrators better manage networks for end-users; and content providers securely route content between multiple locations. Moreover, the product offers carriers multiple access options, including Ethernet over copper, and is supported by dedicated carrier provisioning and care groups.
XO Carrier MPLS IP-VPN is also designed to support customers looking to migrate away from legacy Frame and ATM networks to IP-based communications infrastructures. Using the solution, carriers can integrate clients' varying traffic types from existing legacy networks onto one network, facilitating the transition to a single, converged IP communications strategy.
"XO was a pioneer in delivering IP services and has built on this expertise to provide an MPLS IP-VPN platform that wholesale customers can depend upon for the reliable, secure transport of their customers' voice and data traffic," said Cindy Whelan, Principal Analyst, Current Analysis. "Enterprise demand for MPLS IP-VPN services will continue to grow, and XO's Carrier MPLS IP-VPN offers the flexibility in access methods, high-capacity interfaces, service quality assurances and network management tools that carriers need to deliver a first-rate MPLS IP-VPN service to their end-users."
XO Carrier MPLS IP-VPN Features
XO Carrier MPLS IP-VPN enables customers to offer prioritization of mission-critical traffic such as voice, video and data applications over non-urgent traffic types such as e-mail and Web browsing. By prioritizing traffic, clients can safeguard high-priority traffic over low-priority traffic, while not having to increase bandwidth purely to support non-critical applications.
The service also allows for allocating bandwidth and prioritizing applications. What's more, any class of service can utilize up to the full available bandwidth without incurring additional charges. Carrier MPLS IP-VPN offers four classes of service:
-- Real Time CoS -- for applications that are very sensitive to latency and jitter, such as VoIP. -- Critical CoS -- for applications that can withstand higher latency and jitter, but still need guarantees on both delay and jitter such as video applications. -- Priority CoS -- for applications which need to take priority, but are not susceptible to variations in latency or jitter such as database applications. -- Standard CoS -- for applications which can withstand moderate to high variations in latency or jitter such as e-mail and Web browsing.
For more information about XO Carrier MPLS IP-VPN, contact an XO sales representative by calling 800.474.1763, 1+ 303.539.7738, or 1+ 972.578.6496.
About XO Communications
XO Communications, a subsidiary of XO Holdings, Inc. (OTCBB: XOHO), is a leading nationwide provider of advanced communications services and solutions for businesses, enterprises, government, carriers and service providers. Its customers include more than half of the Fortune 500, in addition to leading cable companies, carriers, content providers and mobile network operators. Utilizing its unique combination of high-capacity nationwide and metro networks and broadband wireless capabilities, XO offers customers a broad range of managed voice, data and IP services with proven performance, scalability and value in more than 75 metropolitan markets across the United States. For more information, visit www.xo.com.
Media Contact: Cassidy Neveux Reputation Partners (for XO Communications) 312-819-5720 Email Contact
SOURCE: XO Communications
Nice close at the high of the day. Hey, am I talkin' to myself again?. Hello? FBR closed at $.30! Maybe the shorts are finally getting spooked.
lolol
Like it too, and don't forget that there are about 13 million shares short, or 10% of the float.
;)
Looks interesting and cheap! I've been liking MSO. Only 2.7 million in the float, 12% of which are short; it's trading at all-time lows. Martha sold a few of her shares, but still holds 1.384 million. It's a good thing. :)
FBR and FBC and VNBC are lookin' ready to do their thing, imho...all relatively low-floaters with high short interest.
EGT has news today...last run was a beautiful thing.
And now Credit Suisse has increased its position by over 833% to 415,379 shares, reported on 12/29/08.
http://www.mffais.com/fbr.html
When Roger increased the A/S behind our backs, I forgave him because I thought he'd use the money to pay the taxes, mortgages, etc., on the millions of dollars worth of real estate the company had acquired that were now threatened with foreclosure. Ah, but that was not the case. He dumped billions of shares and just disappeared in silence, and only HE knows what he did with that money. He certainly didn't use it to build up the company or save the assets.
History does have a way of repeating itself.
Go CBAY. Yippee.
Wishing everyone a Merry Christmas and a very fine '09!
I've been watchin' the institutional holdings. Some sold out, but several are adding (California Public Retirement; Goldman Sachs increased its position by 594% in mid-November). Brand new positions include Mass Mutual Select and Oppenheimer Funds. Sooner or later...kaboom! (lol)
Best of luck!
;)
http://www.mffais.com/fbr.html
It's an amended and restated employment agreement, and unless I'm missing something, I can't see how this has anything to do with Kratz's proposed purchase of the bank for his paltry $18 million offer. Something crazy is going to happen to this stock sooner or later, and I think (hope!) it's gonna be crazy-good rather than crazy-bad.
;)
.04's - average is .0436. I thought it was unbelievably undervalued and believe it still is.
GLTA!
;)
It's active. The SOS is probably waiting for the check to clear before they take it off of administrative hold.
(their first check...well...sort of BOUNCED back in August)
Yippee. Go CBAY to $.025 (or no deal).
;)